RxPost
PrivateLast Round
Seed
Feb 6, 2026
Est. Valuation
$3M
Total Funding Raised
$1.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RxPost is a healthtech company that provides a DSCSA-compliant digital marketplace and inventory management platform designed to help independent pharmacies buy and sell surplus medication inventory.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Supply Chain, Vertical SaaS, Compliance, Supply Chain Tracking
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxPost Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
RxPost Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 6, 2026 | ||||
| Grant | Oct 14, 2025 | ||||
| Pre Seed | Jan 15, 2025 | ||||
| Grant | Nov 7, 2024 | ||||
| Accelerator | Mar 12, 2024 |
RxPost Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capitalize VC | Pre Seed |
| Fabric VC | Pre Seed |
| Yonder Ventures | Pre Seed |
| Women Founders Network | Grant |
| 1752vc | Pre Seed |
| Slauson & Co. | Pre Seed, Accelerator |
| BFA Global | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 64% MoM, reaching 4.6K.
- Feb 6, 2026
Completed a Seed funding round.
RxPost Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RxPost's valuation, stock price, and market status.